Evidence map›Paper›PMID 38436263›Full record

ReviewMicrobiology and molecular biology reviews : MMBR2024

Physiological adventures in

Kenneth W Nickerson, Daniel J Gutzmann, Cory H T Boone, Ruvini U Pathirana, Audrey L Atkin

Open access · greenAbstract readReview
In one paragraph

Review in Microbiology and molecular biology reviews : MMBR, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Hijacking competitor-derived signals: RcsB/C drivesApplied and environmental microbiology · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Cyclodextrins in action: ModulatingBiotechnology reports (Amsterdam, Netherlands) · 2025
    Article
  11. Antioxidants (Basel, Switzerland) · 2025
    Article
  12. Review
  13. Review
  14. The role of serum albumin inApplied and environmental microbiology · 2024
    Article
  15. ThemBio · 2024
    Article
  16. Absence of farnesol salvage inApplied and environmental microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kenneth W NickersonSchool of Biological Sciences, University of Nebraska, Lincoln, Nebraska, USA.ORCID 0000-0003-0310-6807
Daniel J GutzmannSchool of Biological Sciences, University of Nebraska, Lincoln, Nebraska, USA.ORCID 0000-0001-5352-4826
Cory H T BooneSchool of Biological Sciences, University of Nebraska, Lincoln, Nebraska, USA.ORCID 0000-0003-0975-3677
Ruvini U PathiranaDepartment of Biology and Chemistry, Texas A&M International University, Laredo, Texas, USA.ORCID 0000-0001-9847-2185
Audrey L AtkinSchool of Biological Sciences, University of Nebraska, Lincoln, Nebraska, USA.ORCID 0000-0001-5893-1068
University of Nebraska–Lincoln · USTexas A&M International University · US

Funding

University of Nebraska-Lincoln (NU)
6 · The paper itself

Abstract

SUMMARYFarnesol was first identified as a quorum-sensing molecule, which blocked the yeast to hyphal transition in

Indexed as

Candida albicansFarnesolFungal ProteinsQuorum SensingVirulence FactorsFarnesolFungal ProteinsVirulence FactorsCandida albicansfarnesolfungal dimorphismfusel alcoholsholdase chaperonesmRPMI 1640protein farnesylationquorum sensing

Identifiers

PMID38436263
PMCPMC10966945
OpenAlexW4392378889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.